Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Reviva to Present at the UBS Virtual CNS Day | ||
By: GlobeNewswire - 11 Mar 2024 | Back to overview list |
|
CUPERTINO, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a Fireside Chat at the UBS Virtual CNS Day, taking place virtually March 18, 2024. UBS Virtual CNS Day To register for the event, please click here or contact your UBS representative. About Reviva Corporate Contact: Investor Relations Contact: Media Contact: |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |